Document Classification

Section Type: METHODS

Text: Three hundred eighty-four stage III (6 %) and IV (94 %) oropharyngeal (59. 4 %), hypopharyngeal (32. 3 %), and oral cavity (8. 3 %) cancer patients were randomly assigned to receive either 30 Gy (2 Gy every day) followed by 1. 4 Gy bid to a total of 70. 6 Gy concurrently with FU (600 mg/m (2), 120 hours continuous infusion) days 1 through 5 and MMC (10 mg/m (2)) on days 5 and 36 (C-HART) or 14 Gy (2 Gy every day) followed by 1. 4 Gy bid to a total dose of 77. 6 Gy (HART).